Hawkins, Reed M.
Clinical Research Division and
3 papers on CoChatORCID 0000-0001-8611-2588
Most cited papers
- Verified
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
Turtle, C. J., Hanafi, L.-A., Berger, C., Hudecek, M., Pender, B., Robinson, E., Hawkins, R., Chaney, C., Cherian, S., Chen, X., et al. (2016) · Science Translational Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 1,016
- Verified
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Hirayama, A. V., Gauthier, J., Hay, K. A., Voutsinas, J. M., Wu, Q., Gooley, T., Li, D., Cherian, S., Chen, X., Pender, B. S., et al. (2019) · Blood
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 355
- Verified
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies
Gauthier, J., Bezerra, E. D., Hirayama, A. V., Fiorenza, S., Sheih, A., Chou, C. K., Kimble, E. L., Pender, B. S., Hawkins, R. M., Vakil, A., et al. (2021) · Blood
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 205
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free